Delivery Of Curcumin Nanoliposomes Using Surface Modified With CD133 Aptamers For Prostate Cancer

References

• Qu M, Ren SC, Sun YH. Current early diagnostic biomarkers of prostate cancer. Asian J Androl. 2014;16(4):549–554. doi:10.4103/1008-682X.12921124830695
   PubMed Web of Science ®Google Scholar
• Sowery RD, So AI, Gleave ME. Therapeutic options in advanced prostate cancer: present and future. Curr Urol Rep. 2007;8(1):53–59. doi:10.1007/s11934-007-0021-917239317
   PubMedGoogle Scholar
• Wang L, Ma L, Wang X, Li B, Guo S, Qiao Q. Association of serum EPCA-2 level with prostate cancer in Chinese Han population. Int J Clin Exp Pathol. 2015;8(8):9397–9403.26464694
   PubMed Web of Science ®Google Scholar
• Yang L, Xie S, Feng X, et al. Worldwide prevalence of human papillomavirus and relative risk of prostate cancer: a meta-analysis. Sci Rep. 2015;5:14667. doi:10.1038/srep1466726441160
   PubMed Web of Science ®Google Scholar
• Tan HL, Thomas-Ahner JM, Grainger EM, et al. Tomato-based food products for prostate cancer prevention: what have we learned? Cancer Metastasis Rev. 2010;29(3):553–568. doi:10.1007/s10555-010-9246-z20803054
   PubMed Web of Science ®Google Scholar
• Brenton J, Baguley KA, Bolam ORL, Skinner TL. The effect of nutrition therapy and exercise on cancer-related fatigue and quality of life in men with prostate cancer: a systematic review. Nutrients. 2017;9(9):1003. doi:10.3390/nu9091003
   PubMed Web of Science ®Google Scholar
• Sinha R, Anderson DE, McDonald SS, Greenwald P. Cancer risk and diet in India. J Postgrad Med. 2003;49(3):222–228.14597785
   PubMedGoogle Scholar
• Stan SD, Singh SV, Brand RE. Chemoprevention strategies for pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2010;7(6):347–356. doi:10.1038/nrgastro.2010.6120440279
   PubMed Web of Science ®Google Scholar
• Cimino S, Sortino G, Favilla V, et al. Polyphenols: key issues involved in chemoprevention of prostate cancer. Oxid Med Cell Longev. 2012;2012:632959. doi:10.1155/2012/63295922690272
   PubMed Web of Science ®Google Scholar
• Aggarwal BB. Prostate cancer and curcumin: add spice to your life. Cancer Biol Ther. 2008;7(9):1436–1440. doi:10.4161/cbt.7.9.665918769126
   PubMed Web of Science ®Google Scholar
• Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann N Y Acad Sci. 2005;1056:206–217. doi:10.1196/annals.1352.01016387689
   PubMed Web of Science ®Google Scholar
• Maheshwari RK, Singh AK, Gaddipati J, et al. Multiple biological activities of 18rcumin: a short review. Life Sci. 2006;78(18):2081–2087. doi:10.1016/j.lfs.2005.12.00716413584
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang Y, Banerjee S, Sarkar FH. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer. 2006;106(11):2503–2513. doi:10.1002/cncr.2190416628653
   PubMed Web of Science ®Google Scholar
• Sa G, Das T. Anticancer effects of curcumin: cycle of life and death. Cell Div. 2008;3:14. doi:10.1186/1747-1028-3-1418834508
   PubMed Web of Science ®Google Scholar
• Adahoun MA, A-Akhras MH, Jaafar MS, Bououdina M. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles. Artif Cells Nanomed Biotechnol. 2017;45(1):98–107. doi:10.3109/21691401.2015.112962826747522
   PubMed Web of Science ®Google Scholar
• Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell Stem Cell. 2014;14(3):275291. doi:10.1016/j.stem.2014.02.006
   Web of Science ®Google Scholar
• La Porta CA. Mechanism of drug sensitivity and resistance in melanoma. Curr Cancer Drug Targets. 2009;9(3):391397. doi:10.2174/156800909788166574
   Web of Science ®Google Scholar
• Goksel G, Bilir A, Uslu R, Akbulut H, Guven U, Oktem G. WNT1 gene expression alters in heterogeneous population of prostate cancer cells; decreased expression pattern observed in CD133+/CD44+ prostate cancer stem cell spheroids. J BUON. 2014;19(1):207–214.24659666
   PubMed Web of Science ®Google Scholar
• Islami M, Mortazavi Y, Soleimani M, Nadri S. In vitro expansion of CD 133+ cells derived from umbilical cord blood in poly-L-lactic acid (PLLA) scaffold coated with fibronectin and collagen. Artif Cells Nanomed Biotechnol. 2017;6:1–9.
   Web of Science ®Google Scholar
• Li S, Wang XP. In vitro and in vivo evaluation of novel NGR-modified liposomes containing brucine. Int J Nanomedicine. 2017;12:5797–5804. doi:10.2147/IJN.S13637828860749
   PubMed Web of Science ®Google Scholar
• Keefe AD, Pai S, Ellington A. Aptamers as therapeutics. Nat Rev Drug Discov. 2010;9(7):537–550. doi:10.1038/nrd314120592747
   PubMed Web of Science ®Google Scholar
• Shigdar S, Qiao L, Zhou SF, et al. RNA aptamers targeting cancer stem cell marker CD133. Cancer Lett. 2013;330(1):84–95. doi:10.1016/j.canlet.2012.11.03223196060
   PubMed Web of Science ®Google Scholar
• Ma J, Zhuang H, Zhuang Z. et al. Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting. Artif Cells Nanomed Biotechnol;2017 1–8. doi:10.1080/21691401.2017.1394874
   Web of Science ®Google Scholar
• Gao J, Liu W, Xia Y, et al. The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes. Biomaterials. 2011;32(13):3459–3470. doi:10.1016/j.biomaterials.2011.01.03421296406
   PubMed Web of Science ®Google Scholar
• Gao J, Sun J, Li H, et al. Lyophilized HER2-specific PEGylated immunoliposomes for active siRNA gene silencing. Biomaterials. 2010;31(9):2655–2664. doi:10.1016/j.biomaterials.2009.11.11220035999
   PubMed Web of Science ®Google Scholar
• Shi B, Fang C, You MX. Stealth MePEG-PCL micelles: effects of polymer composition on micelle physicochemical characteristics, in vitro drug release, in vivo pharmacokinetics in rats and biodistribution in S180 tumor bearing mice. Colloid Polym Sci. 2005;283:954–967. doi:10.1007/s00396-004-1243-8
   Web of Science ®Google Scholar
• Zu YG, Meng L, Zhao XH, et al. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery. Int J Nanomedicine. 2013;8:1207–1222. doi:10.2147/IJN.S4049323569373
   PubMed Web of Science ®Google Scholar
• Lian H, Sun J, Yu YP, et al. Supramolecular micellar nanoaggregates based on a novel chitosan/vitamin E succinate copolymer for paclitaxel selective delivery. Int J Nanomedicine. 2011;6:3323–3334. doi:10.2147/IJN.S2630522228999
   PubMed Web of Science ®Google Scholar
• Ray S, Ghosh Ray S, Mandal S. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer. Artif Cells Nanomed Biotechnol. 2017;45(5):944–954. doi:10.1080/21691401.2016.119645727327352
   PubMed Web of Science ®Google Scholar
• Yang JP, Liu Y, Zhong W, et al. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma. Chin Med J (Engl). 2011;124:1055–1060.21542968
   PubMed Web of Science ®Google Scholar
• Celia C, Calvagno MG, Paolino D, et al. Improved in vitro anti-tumoral activity, intracellular uptake and apoptotic induction of gemcitabine-loaded pegylated unilamellar liposomes. J Nanosci Nanotechnol. 2008;8(4):2012–2013. doi:10.1166/jnn.2008.065
   Web of Science ®Google Scholar
• Dong X, Zou S, Guo C, et al. Multifunctional redox-responsive and CD44 receptor targeting polymer-drug nanomedicine based curcumin and alendronate: synthesis, characterization and in vitro evaluation. Artif Cells Nanomed Biotechnol. 2017;1–10.
   PubMed Web of Science ®Google Scholar